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Temperature-dependent release of ATP from human
erythrocytes: mechanism for the control of local tissue
perfusion
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Centre for Sports Medicine and Human Performance, Brunel University, Uxbridge, Middlesex, UK
Human limb muscle and skin blood flow increases significantly with elevations in temperature,
possibly through physiological processes that involve temperature-sensitive regulatory
mechanisms. Here we tested the hypothesis that the release of the vasodilator ATP from human
erythrocytes is sensitive to physiological increases in temperature both in vitro and in vivo,
and examined potential channel/transporters involved. To investigate the source of ATP release,
whole blood, red blood cells (RBCs), plasma and serum were heated in vitro to 33, 36, 39 and
42◦C. In vitro heating augmented plasma or ‘bathing solution’ ATP in whole blood and RBC
samples, but not in either isolated plasma or serum samples. Heat-induced ATP release was
blocked by niflumic acid and glibenclamide, but was not affected by inhibitors of nucleoside
transport or anion exchange. Heating blood to 42◦C enhanced (P< 0.05) membrane protein
abundanceof cysticfibrosis transmembraneconductance regulator (CFTR) inRBCs. Inaparallel
in vivo study in humans exposed to whole-body heating at rest and during exercise, increases
in muscle temperature from 35 to 40◦C correlated strongly with elevations in arterial plasma
ATP (r2 = 0.91; P = 0.0001), but not with femoral venous plasma ATP (r2 = 0.61; P = 0.14).
In vitro, however, the increase in ATP release from RBCs was similar in arterial and venous
samples heated to 39◦C. Our findings demonstrate that erythrocyte ATP release is sensitive
to physiological increases in temperature, possibly via activation of CFTR-like channels, and
suggest that temperature-dependent release of ATP from erythrocytes might be an important
mechanism regulating human limb muscle and skin perfusion in conditions that alter blood
and tissue temperature.
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Internal body temperature is a highly regulated
physiological process in humans and other homeothermic
animals. However, large regional differences in
temperature still exist between internal organs and
limb tissues, with the latter being 2–5◦C lower in
humans and larger animals in normal resting conditions
(Bazett & McGlone, 1927; He et al. 2002). These
temperature differences are also highlighted during
exercise, when the temperature of the blood and
muscle of the exercising limbs can increase from 33–
35 to 40–41◦C while in non-exercising limbs it remains
essentially unchanged (Saltin et al. 1972; Gonza´lez-
Alonso et al. 1999a,b). Hence, RBCs can be exposed to
drastic changes in temperature as they travel through
tissues with different metabolic heat production and
haemodynamic demands. Although recent evidence in
heat-stressedhumans supports a close associationbetween
the elevations in limb tissue perfusion and the increases
in muscle temperature and arterial plasma adenosine 5′-
triphosphate (ATP; Pearson et al. 2011), the ATP source
and temperature-sensitive mechanisms involved remain
unknown.
The erythrocytes, the major oxygen carriers in the
blood, have been hypothesized to play a crucial role
in the control of local tissue blood flow. According
to the hypothesis proposed by Ellsworth et al. (1995),
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when the erythrocytes encounter an area where metabolic
demands are augmented a signalling mechanism coupled
to the offloading of oxygen is triggered, resulting in the
release of ATP from the erythrocytes into the vascular
lumen. The ATP acts upon the endothelial P2y receptors,
triggering the release of nitric oxide, prostaglandins and/or
endothelium-derived hyperpolarizing factor, which in
turn act upon the surrounding smooth muscle cells to
cause vasodilatation (Ellsworth et al. 1995; Sprague et al.
1996; Mortensen et al. 2009a,b). The release of ATP from
erythrocytes can occur not only in response to a reduction
in PO2 , but also in response to blood cell deformation
(Sprague et al. 1998; Fischer et al. 2003). The endothelium
could be another source of ATP; however, catabolic
ectonucleotidases (Zimmermann, 2006b) present on
the surface of cellular membranes (Gordon, 1986;
Zimmermann, 2006a) immediately convert intravascular
ATP to adenosine, thereby evoking P1 receptor-mediated
vasodilatation (Deussen et al. 1986). It has long been
known that an increase in temperature reduces the
affinity of haemoglobin for oxygen (Barcroft & King,
1909; Duc & Engel, 1969). This suggests that temperature
has the potential to modulate the release of ATP from
erythrocyte directly or indirectly; however, no study to
date has systematically investigated whether temperature
per se is a major stimulus for the release of ATP from
erythrocytes.
The mechanisms of ATP release from erythrocytes are
thought to involve membrane-bound ion channels, gap
junction proteins, such as pannexin 1, and/or members of
the ATP-binding cassette proteins (ABC proteins), such as
the cystic fibrosis transmembrane conductance regulator
(CFTR; Bergfeld & Forrester, 1992; Abraham et al. 1993;
Locovei et al. 2006). The impact of temperature on
these channels/transporters is not known.Themembrane-
bound ion channel known as band 3 (also known as the
anion exchanger AE1) was the first channel proposed
to regulate the release of ATP from erythrocytes with
exposure to hypoxia (Bergfeld & Forrester, 1992). More
recently, the gap junction protein pannexin 1, which
is also abundantly expressed in erythrocytes, has been
postulated to formATP-permeable channels in the plasma
membrane, and responds to low oxygen tension through
its action on the signal transduction pathway leading
to ATP release (Locovei et al. 2006; Sridharan et al.
2010). Lastly, the CFTR channels in erythrocytes and
other cells have been shown to be activated by external
physiological stimuli, such as cell deformation, cell
swelling and changes in pH (Sprague et al. 1998; Gourine
et al. 2010; Tu et al. 2010). Whether the aforementioned
channels/transporters are involved in the release of ATP
fromerythrocyteswhen temperature is increasedhasnever
been examined.
The main purpose of this study, therefore, was to
investigate the source and the temperature-sensitive
mechanismofATP release in humanblood. To accomplish
this overall aim, the following investigations were carried
out: (i) whole blood and its separate constituents were
heated in vitro to establish the primary source of ATP;
(ii) specific and non-specific channel inhibitors were used
to block in vitro ATP release from human erythrocytes to
understand the mechanism of heat-induced ATP release;
(iii) blood samples from healthy volunteers exposed to
heat stress in resting and exercising conditions were
assessed to examine whether ATP release was comparable
to the response observed in our in vitro experiments; and
(iv) arterial and venous blood was heated in vitro to assess
whether the oxygenation status of the blood affects the
amount of ATP release. We hypothesize that the release of
ATP from human erythrocytes is sensitive to physiological
increases in temperature per se, both in vitro and in vivo,
and that channels localized in the erythrocyte membrane
are involved in this process.
Methods
This study, consisting of five in vitro protocols and one in
vivo protocol (i.e. protocols 1–6) conformed to the code
of Ethics of the World Medical Association (Declaration
of Helsinki) and was conducted after receiving ethical
approval from the Brunel University Research Ethics
Committee. Informed written and verbal consent was
obtained from all of the participants before commencing
with any part of this study. Subjects were asked to refrain
from exercise and ingestion of caffeine on the day of blood
withdrawal.
Blood samples for the in vitro heating protocols 1–
4 were obtained by venepuncture of an antecubital
vein in 27 healthy men ranging in age from 21 to
46 years (mean± SD age 28± 7 years) and were tested
on the day of collection (within 30–50min of blood
collection). Blood was always collected in a syringe and
immediately aliquoted intoK3-EDTAor serum separation
tubes. For protocol 5, 10 healthy recreationally active
men (mean± SD age 21± 2 years) participated in a
graded whole-body heating protocol, which has been
described in detail previously (Pearson et al. 2011).
Only during this protocol, arterial and venous blood
samples were assayed immediately after collection. In
protocol 6, arterial and venous blood was collected from
four subjects (mean± SD age 31± 6 years) in a syringe
and immediately aliquoted into K3-EDTA. The red blood
cells (RBCs) were then heated in vitro.
Protocol 1: effect of heating on ATP release from
blood constituents in vitro
The main aim of this protocol was to determine the
source of ATP by heating whole blood and the separate
C© 2012 The Authors. Experimental Physiology C© 2012 The Physiological Society
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constituents of blood. Blood was collected from 10
individuals for this part of the study. Blood collected in
EDTA tubes was separated into eppendorf tubes and kept
as whole blood or centrifuged at 15,493g for 30 s at room
temperature. Plasma was removed and transferred into
new tubes; the buffy coat was removed and discarded,
while the RBC fraction was also kept for experimentation.
The volume was restored by adding physiological saline
after plasma and buffy coat removal from the RBC
fraction. Tubes used for serum separation were coated
with silicon and micronized silica particles to accelerate
clotting (SST II advance serum separation tubes; Becton
& Dickinson, Oxford, UK). Blood was allowed to clot for
30min at room temperature, and serum was collected
after centrifugation for 10min at 1000g . Aliquots (0.5 ml)
of whole blood, RBCs, plasma and serum were heated
for 20min (Baar, 1967) in stirred water baths set at
33 (control), 36, 39 and 42◦C. Prior to the heating
protocol, initial levels of ATP and free haemoglobin were
measured. To further determine the effects of heating
on whole blood haematological parameters, RBC count,
total haemoglobin, haematocrit, mean cell volume, mean
cell haemoglobin and mean corpuscular haemoglobin
concentration were measured using an automatic
haematology analyser (Sysmex KX-21N; Sysmex UK Ltd,
Milton Keynes, UK) after repeated blood samples from
one individual were incubated for 20min at 33, 36, 39
and 42◦C.
Protocol 2: time course for in vitro heat-dependent
erythrocyte ATP release
The aim of this protocol was to ascertain the time course
of the increase in ATP release from human erythrocytes
with heating over 20min. Tubes with RBCs were initially
placed in a water bath set at 33◦C, where the temperature
was continuously monitored by a thermocouple inserted
into a tube containing RBCs. Once the temperature was
stable at 33◦C for ∼5min, a set of tubes containing RBCs
were moved to a water bath maintained at 42◦C. Another
tube containing RBCs with a second thermocouple was
used to indicate the time needed to reach 42◦C starting
from 33◦C. Samples were removed from the water baths
set at 33 and 42◦C after 1, 3, 5, 10, 15 and 20min. At each
time point, the temperature was noted and samples were
rapidly prepared for ATP analysis. Data were collected
from six to 10 healthy individuals.
A further set of RBC samples (n = 6) were heated
to 42◦C for 20min and then moved to a water
bath set at 33◦C. Samples were removed at regular
intervals for ATP analysis. Release of ATP was compared
with control samples kept at 33◦C. In these sets of
experiments, the number of RBCs was counted using a
haemocytometer for samples before and after 20min of
heating.
Protocol 3: effect of inhibitors of ATP channels and
transporters on heat-dependent erythrocyte ATP
release
In order to distinguish the potential channel or transporter
involved in the heat-dependent ATP release from
erythrocytes, various inhibitors were used to block the
release during in vitro heating. Isolated RBCs were
incubated for 20min in water baths set at 33 (control)
and 39◦C with various inhibitors of band 3 and band 4.5.
The inhibitors used to block band 3 transport included
niflumic acid, whichwas dissolved in physiological (0.9%)
saline, and DIDS, dissolved in 2% DMSO. The inhibitor
used to block band 4.5 nucleoside translocation was
nitrobenzylthioinosine (NBTI) dissolved in DMSO. Stock
solutions of inhibitors were prepared so that the final
concentration of DMSO was less than 1% and did not
induce haemolysis.
Red blood cells isolated from arterial and venous blood
samples, collected during protocol 6, were incubated for
20min in water baths set at 33 (control) and 39◦C with
400μmol l−1 niflumic acid or 400μmol l−1 glibenclamide
(an ATP-sensitive potassium channel blocker which
also blocks CFTR; Sheppard & Robinson, 1997).
Glibenclamide was prepared as a 0.01mol l−1 stock
solution in 0.1 N NaOH and 50mgml−1 dextrose solution
and heated at 52◦C to dissolve (Sprague et al. 1998). The
effect of vehicle alone was also tested. All chemicals were
purchased from Sigma-Aldrich (Gillingham, UK).
Protocol 4: effect of in vitro heating on CFTR
abundance in erythrocyte ghost membrane isolation
The purpose of this protocol was to investigate whether
CFTR protein in the membranes of erythrocytes was
involved in the heat-dependent release of ATP. Human
red blood cell ghost membranes were prepared from
RBCs according to the method of Sterling et al. (2004)
after they were exposed to 33 and 42◦C for 20min.
The purified RBC membranes were dissolved using
50mmol l−1 Tris–HCl (pH 7.5), 150mmol l−1 NaCl, 1%
Triton X-100 and 1%Nonidet P-40 plus protease inhibitor
cocktail. For the enzyme-linked immunosorbent assay
(ELISA), a microtitre 96-well plate was coated with
the dissolved membrane extracts in carbonate buffer
(15mmol l−1 Na2CO3 and 35mmol l−1 NaHCO3, pH 9.6)
and incubated overnight at 4◦C. Blocking buffer of 2%
bovine serum albumin in PBS was added and incubated
for 1 h at 37◦C. After washing with PBS, wells were
incubated with rabbit polyclonal antibodies raised against
the amino terminus of human CFTR diluted 1:2000
in PBS (New England Biolabs, Hitchin, UK) for 1 h
at 37◦C and 2 h at 4◦C. After washing with 0.02%
Tween 20 in PBS, wells were treated with human anti-
protein A conjugated to horseradish peroxidase (Sigma)
C© 2012 The Authors. Experimental Physiology C© 2012 The Physiological Society
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diluted to 1:3000 in PBS and incubated at 37◦C for 1 h.
The reaction was developed using o-phenylenediamine
dihydrochloride (SigmaFASTTM). Ghost membranes were
prepared from blood taken from six subjects, and the
ELISA was carried out as an average of three repetitions.
Bovine serum albumin alone was used as a negative
control to test the specificity of the CFTR antibody. Total
protein was determined by the bicinchoninic acid assay
(Sigma).
Procotol 5: effect of heating on intravascular ATP in
vivo
To gain an insight regarding the effect of heating on
intravascular ATP release in vivo, blood samples collected
from subjects undergoing graded whole-body heating
were assayed immediately after collection. In brief, muscle
temperature and blood samples were obtained at rest and
after 6 min ofmoderate one-legged knee-extensor exercise
(mean± SEM, 21± 1W) in the following four different
thermal conditions while wearing a water-perfused suit:
(i) control; (ii) mild heating; (iii) moderate heating; and
(iv) severe heating. Catheters were inserted into the
femoral vein of the exercising leg (left leg) and in the radial
artery (right forearm)using the Seldinger technique under
local anaesthesia (1% lidocaine, Hameln Pharmaceuticals,
Gloucester, UK). Quadriceps muscle temperature was
measured in real time (TC-2000; Sable Systems, Las Vegas,
NV,USA)with aT-204A tissue-implantable thermocouple
microprobe (Physitemp, Clifton, NJ, USA). Arterial and
venous blood samples were collected in tubes containing
stop solution (for details see section below on ‘Blood
sample treatment ’) at rest and at 5 min of exercise during
each experimental condition.
Protocol 6: effect of in vitro heating on
heat-dependent erythrocyte ATP release from arterial
and venous blood samples
The aim of this protocol was to determine any differences
in ATP release from arterial and venous erythrocytes
exposed to in vitro heating. Subjects rested in a supine
position while two catheters were inserted as described
in the previous subsection; one was placed into the
radial artery of the right arm and the other into the
median cubital vein of the left arm. Arterial and venous
blood samples were collected in EDTA tubes. The RBCs
were immediately isolated by centrifuging whole blood at
15,493g for 30 s at room temperature followed by removal
of plasma. The samples were then subjected to the in vitro
heating protocol in water baths set at 33 and 39◦C for
20min. Blood haemoglobin oxygen saturation and PO2
were measured immediately upon collection in separate
samples using a blood gas analyser (ABL 825; Radiometer,
Copenhagen, Denmark).
Blood sample treatment
Blood samples (2 ml) obtained during the in vivo
experiment (protocol 5) were collected directly in
stop solution (2.7 ml) containing S-(4-nitrobenzyl)-
6-thioinosine (NBTI; 5 nmol l−1), 3-isobutyl-1-
methylxanthine (IBMX; 100μmol l−1), forskolin
(10μmol l−1), EDTA (4.15mmol l−1), NaCl
(118mmol l−1), KCl (5 mmol l−1) and tricine buffer
(40mmol l−1) developed by Gorman et al. (2003). This
stop solution prevents any further release andmetabolism
of ATP, and values have been shown to remain stable
for ∼30min (Gorman et al. 2003, 2007). Blood samples
were weighed to enable precise calculation of the blood
volumes and determine the dilution factor for the ATP
concentration. To samples undergoing the in vitro heating
protocol, stop solution was added after 20min of heating.
Samples were immediately centrifuged for 30 s at 15,493g ,
and the supernatant was transferred into new tubes for
ATP and haemoglobin determination.
Measurement of ATP and haemoglobin
The ATP was determined with the luciferin–luciferase
technique, using a luminometer with three automatic
injectors (Orion Microplate Luminometer; Berthold
Detection System GmbH, Pforzheim, Germany). ATP
in the supernatant was measured in duplicate at room
temperature (20–22◦C) using an ATP kit (ATP Kit SL;
BioThema AB, Dalaro¨, Sweden) with an internal ATP
standard procedure. According to the manufacturer,
free haemoglobin does not interfere with the analysis,
and the minimum detectable concentration of ATP
is 10−12 mol l−1, while the maximum is 10−6 mol l−1.
Haemoglobin was measured to estimate the degree of
haemolysis by reading the absorbance of the supernatants
at 560, 577 and 593 nm (Cripps, 1968) with a
spectrophotometer (Jenway 3500; Bibby Scientific, Stone,
UK). Haemoglobin concentration (in grams per litre) was
calculated from the absorbances (A) by {177.6× [A577 –
(A560 + A593)/2]}, where 177.6 is the calibration coefficient
k (Malinauskas, 1997). The effect of temperature on
haematocrit was assayed by incubating whole blood
for 20min in the different water baths, at the end of
which the haematocrit was determined in duplicate by
microcentrifugation (Dill & Costill, 1974).
Statistical analysis
A one-way repeated-measures ANOVA was performed
on all dependent variables to test significance among
C© 2012 The Authors. Experimental Physiology C© 2012 The Physiological Society
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the initial and heating conditions. When a significant
difference (P< 0.05) was found, appropriate post hoc
analysis was conducted (i.e. Tukey’s HSD test) using a
Bonferroni correction when the data were not normally
distributed (P< 0.0125). Correlation between muscle
temperature and plasma ATP was determined using
Pearson’s product–moment correlation.
Results
Effect of increases in temperature on ATP release
from blood constituents in vitro
Whole blood heated for 20min at 39 and 42◦C released
significantly more ATP than at 33◦C, increasing from
1.10± 0.08 to 1.61± 0.20 and 1.66± 0.12μmol l−1,
respectively (P< 0.05; Fig. 1A). When compared with the
initial levels, ATP release was significantly elevated at all
temperatures ≥36◦C. Moreover, a close correlation was
observed betweenATP release andwater bath temperature
(r2 = 0.86; P = 0.074).
When the RBC fraction alone was heated, the
magnitude of ATP release compared with whole blood
heated at the same temperatures was more than twofold
higher (Fig. 1B). The ATP release from RBCs increased
progressively and significantly from 0.79± 0.11μmol l−1
at 33◦C to 3.54± 0.47μmol l−1 at 42◦C (r2 = 0.96;
P = 0.021). To demonstrate that the ATP was released
from RBCs and not from any other blood constituents
contained within the sample, RBCs were also prepared by
washing three times in a buffered solution as described by
Olearczyk et al. (2004). After heating, a similar correlation
was demonstrated, where ATP release was augmented
with increasing temperature from 1.18± 0.23μmol l−1 at
33◦C to 3.69± 0.75μmol l−1 at 42◦C(r2 = 0.93;P = 0.033;
data not shown). In contrast, no changes were apparent
in plasma samples, and ATP levels were significantly
lower than in either whole blood or RBC samples
(Fig. 1C).
Heat had the opposite effect onATP release from serum,
as ATP levels declined significantly in the heated serum
samples compared with initial levels. Moreover, the ATP
concentration in serum samples was significantly lower
compared with initial levels found in whole blood, RBC
or plasma (Fig. 1D). When considered collectively, the
initial startingATP levelswere∼1μmol l−1 inwhole blood
and RBCs,∼0.5μmol l−1 in plasma and∼0.2μmol l−1 in
serum. With heating to 42◦C, ATP release nearly doubled
in whole blood, increased by nearly fourfold in RBCs,
remained unchanged in plasma and decreased by 10-fold
in serum.
Free haemoglobin concentration remained unchanged
with increasing temperature in whole blood, RBC, plasma
or serum samples (P ranged from 0.48 to 0.98; Table 1).
Likewise, whole blood haemotological responses also
Figure 1. Initial ATP and the effect of increasing temperature
on whole blood (A), erythrocytes (B), plasma (C) and serum (D)
Open bar, initial starting ATP (n = 7–12); filled bars, ATP release
after heating for 20 min (n = 7–10). Data are shown as
means ± SEM. ∗Significantly different from 33◦C (control),
P < 0.05. # Significantly different from 36◦C, P < 0.05.
† Significantly different from initial, P < 0.05.
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Table 1. Free haemoglobin levels in bathing solution after heating the different components of
blood
Initial 33◦C 36◦C 39◦C 42◦C
Free haemoglobin (g l−1)
Whole blood 0.14 ± 0.01 0.20 ± 0.02 0.22 ± 0.03 0.23 ±0.03 0.25 ± 0.03
Erythrocytes 0.18 ± 0.05 0.15 ± 0.02 0.14 ± 0.02 0.15 ± 0.02 0.17 ± 0.03
Plasma 0.07 ± 0.01 0.07 ± 0.01 0.08 ± 0.01 0.07 ± 0.01 0.07 ± 0.01
Serum 0.03 ± 0.002 0.03 ±0.001 0.03 ± 0.002 0.03 ± 0.002 0.03 ± 0.001
Data are shown as means ± SEM of n = 7–10.
remained unaltered after incubation for 20min at 33, 36,
39 and 42◦C (Table 2).
Time course of the temperature-dependent release of
ATP from human erythrocytes
The temperature of the RBC solution increased from
33.0± 0.2 to 41.3± 0.2 and 42.0± 0.1◦C after 1 and
3min and remained at ∼42◦C for the remaining 15min
incubation period. In contrast, it remained at ∼33◦C in
the control conditions throughout the 20min incubation
period. In the heated samples, the time needed to induce
a significant elevation in ATP release from RBCs was
5min and did not increase any further for the rest
of the 20min incubation time (Fig. 2). However, when
comparing differences between conditions during the first
5 min (n = 10),ATPreleasewas significantly elevatedat 1, 3
and 5min at 41–42◦C compared with samplesmaintained
at 33◦C (P ranged from 0.023 to 0.001).
Conversely, when samples heated to 42◦C for 20min
were moved to a water bath set at 33◦C, ATP release
dropped sharply, so that after 10min it was back to
similar levels of ATP found in samples that remained
at 33◦C (Fig. 3). These continued to remain stable after
15min and, in further samples, even after 60min (data
not shown). Normalization of the data to the numbers
of RBCs demonstrated that at 33◦C the ATP release was
1.6± 0.2μmol per 108 RBCs, while heating to 42◦C ATP
release was increased to 3.4± 0.4μmol per 108 RBCs
(P = 0.033). No difference in the number of red cells
was observed after heating at 42 compared with 33◦C
(i.e. 3.7± 0.4× 109 versus 3.7± 0.2× 109 RBCsml−1,
respectively; P = 0.84).
Effect of ATP channel and transporter blockers on
temperature-dependent release of ATP from RBCs
An attempt to block the heat-induced ATP release from
RBCs was carried out using 100, 200 and 400μmol l−1
doses of niflumic acid. This was conducted at a
temperature of 39◦C, evoking a more than threefold
increase in ATP release compared with the control
conditions at 33◦C (Fig. 4). Incubation of RBCs with
different concentrations of niflumic acid at 33◦C for
20min did not alter the release of ATP, and values
were comparable to control (Fig. 4A). In the presence of
increasing concentrations of niflumic acid, heat-induced
ATP release was significantly attenuated by 68± 6 to
91± 6% (Fig. 4A; all P< 0.01).
Use of the band 3 transporter inhibitor DIDS did not
inhibit the heat-induced ATP release from RBCs even
at the highest concentration of 400μmol l−1 (P< 0.05;
Fig. 4B), nor did DIDS increase temperature-mediated
ATP release, despite its significant effect on ATP release
at 33◦C at the two higher concentrations, possibly due to
haemolysis (Table 3). In contrast, there was a slight but
not significant 18± 6% inhibition of ATP release in the
presence of the nucleoside inhibitor NBTI. In contrast
Table 2. Haematological responses after heating whole blood samples at different
temperatures
Water bath temperature (◦C)
Variables Initial 33 36 39 42
RBCs (× 106 μl−1) 5.2 ± 0.1 5.1 ± 0.1 5.1 ± 0.1 5.1 ± 0.1 5.2 ± 0.1
Hb (g l−1) 155 ± 2 154 ± 1 155 ± 3 152 ± 4 156 ± 1
Haematocrit (%) 44.2 ± 0.5 44.0 ± 0.3 43.7 ± 0.9 43.4 ± 1.1 44.4 ± 0.3
MCV (fl) 85.4 ± 0.5 85.5 ± 0.2 85.8 ± 0.1 85.8 ± 0.1 85.9 ± 0.1
MCH (pg) 30.1 ± 0.1 30.0 ± 0.1 30.3 ± 0.1 30.2 ± 0.1 30.2 ± 0.1
MCHC (g l−1) 352 ± 1 351 ± 1 353 ± 1 352 ± 1 352 ± 2
Values are means ± SEM from one individual tested eight times. Abbreviations: RBC, red
blood cells; Hb, total haemoglobin concentration; MCV, mean cell volume; MCH, mean cell
haemoglobin; and MCHC, mean corpuscular haemoglobin concentration.
C© 2012 The Authors. Experimental Physiology C© 2012 The Physiological Society
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to DIDS, no significant changes in free haemoglobin were
observedwith niflumic acid orNBTI, at either 33 or 39◦C.
Effect of CFTR inhibition with glibenclamide on
temperature-dependent release of ATP from RBCs
To assess the involvement of CFTR on temperature-
sensitive ATP release, RBCs were incubated in the
presence of glibenclamide. In the same samples of
RBCs, the effect of 400μmol l−1 niflumic acid was also
demonstrated. Both glibenclamide and niflumic acid
completely blocked the release of ATP (P< 0.05; Fig. 5).
Similar to niflumic acid, a dose-dependent inhibitionwith
was observed glibenclamide, with a reduction starting
at 100, 200 and 400μmol l−1 (data not shown). Free
haemoglobin levels in the presence of either niflumic acid
or glibenclamide were unchanged at both 33 and 39◦C
(∼0.1± 0.01 g l−1).
Figure 2. Time-dependent release of ATP from red blood cells
(RBCs)
Samples heated to 42◦C were compared with samples
maintained at a constant temperature of 33◦C (A). The
temperature of RBC samples incubated in water baths set at 33
and 42 ◦C (B). Data are shown as mean ± SEM, n = 6.
∗
Significantly different from 0 min, P < 0.01. † Significantly
higher than 33◦C, P < 0.05.
Abundance of CFTR protein in RBCs subjected to
heating
To confirm the involvement of CFTR in temperature-
dependent ATP release, protein abundance in ghost
membranes was assessed by ELISA. In RBCs heated at 33
and 42◦C isolated from blood from six individuals, CFTR
abundance increased by 42± 14% (P< 0.05; Fig. 6).
Protein determined by bicinchoninic acid assay confirmed
that the concentrations of total protein in ghostmembrane
samples incubated at 33 and 42◦C were similar (5.0± 0.5
and 4.9± 0.5 mgml−1, respectively). Further evidence of
the effect of temperature on the abundance of CFTR in
RBCmembranes was observed when samples were cooled
down to 33◦C for 15min after heating at 42◦C for 20min.
The CFTR abundance in these samples prepared from
blood taken in two individuals declined towards control
values.
Effect of increases in temperature on arterial and
venous plasma ATP in vivo
Graded whole-body heating in human participants
increased quadriceps muscle temperature at rest from
35.3± 0.4◦C in control conditions to 37.0± 0.1◦C with
mild heating, 37.9± 0.3◦C with moderate heating and
finally to 38.8± 0.4◦C with severe heating. During
exercise, the equivalent valueswere 37.3± 0.3◦C in control
conditions 38.1± 0.2◦C with mild heating, 38.9± 0.3◦C
with moderate heating and 39.6± 0.3◦C with severe
heating. A significant correlation was observed between
the rise in muscle temperature and the increase in
arterial plasma ATP during both rest and exercise
(r2 = 0.91; P = 0.0001; Fig. 7). This relationship was
attenuated in venous plasma ATP samples taken during
Figure 3. Release of ATP from RBCs with cooling after heating
Samples were heated to 42◦C for 20 min and then moved to
33◦C. Control samples remained at 33◦C throughout. Data are
shown as means ± SEM, n = 6. ∗Significantly higher than 33◦C,
P < 0.05.
C© 2012 The Authors. Experimental Physiology C© 2012 The Physiological Society
426 K. K. Kalsi and J. Gonza´lez-Alonso Exp Physiol 97.3 (2012) pp 419–432
rest and exercise (r2 = 0.61; P = 0.137). Arterial or venous
plasma haemoglobin remained unchanged with graded
whole-body heating, indicating that haemolysis did not
contribute to the increase in plasma ATP (∼0.1± 0.01 g
l−1 for both arterial and venous samples).
Effect of increases in temperature on ATP release from
erythrocytes in arterial and venous samples in vitro
The ATP release was compared in RBCs heated in vitro at
33 or 39◦C from arterial and venous blood samples taken
in control resting conditions. The haemoglobin oxygen
saturation in the arterial and venous blood was 98.5± 0.3
and 51.2± 6.2%, respectively, with corresponding PO2
values of 105± 1 and 35± 4mmHg. The release of
Figure 4. Release of ATP in the presence of niflumic acid (A) or
DIDS or nitrobenzylthioinosine (NBTI; B) from erythrocyte
samples heated to 39◦C compared with control conditions
(33◦C)
Open bars, ATP release at 33◦C; filled bars, ATP release at 39◦C.
Data are shown as means ± SEM for six subjects. ∗Significantly
lower than control 39◦C, P < 0.05. † Significantly different from
each respective condition at 33◦C. # Significantly higher than
control 33◦C, P < 0.05.
ATP was comparably increased to 1.69± 0.30 and
2.26± 0.53μmol l−1 (P< 0.05) in both arterial and
venous samples heated at 39◦C from 0.78± 0.17
and 0.65± 0.09μmol l−1 at 33◦C, respectively (Fig. 8).
Furthermore, the responses of both arterial and venous
RBCs to niflumic acid were similar, indicating that the
sensitivities of the temperature-sensitive ATP transporters
were not affected by the oxygenation status of the RBCs,
because they demonstrated complete inhibition (P< 0.05;
Fig. 8).
Discussion
This study reveals six key findings that provide novel
insight into the blood source and the temperature-
sensitive mechanisms of ATP release in human red blood
cells. First, the erythrocytes were the primary source
of ATP from blood-formed elements. Second, cooling
after heating restored erythrocyte ATP release to baseline
levels. Third, heat-mediated erythrocyte ATP release was
completely blocked by either niflumic acid (a non-specific
ion channel inhibitor which blocks Ca2+-activated Cl−
channels) or glibenclamide (an inhibitor ofCFTR)butwas
not blocked by inhibitors of nucleoside transport or anion
exchange. Forth, heating the blood enhanced protein
abundance of CFTR in membrane protein fractions
isolated fromRBCs. Fifth, in vitro findings were consistent
with the progressive increase in arterial plasma ATP
observed in vivo in resting and exercising heat-stressed
humans. Sixth, in vitro, however, the increase in ATP
release from RBCs was similar in arterial and venous
samples, suggesting that the lower in vivo rate of increase
in venous plasma ATP with temperature might be due
to increased ATP degradation. These findings collectively
demonstrate that erythrocyte ATP release is sensitive
to physiological increases in temperature via CFTR-
like channels and imply the existence of a potentially
importantmechanism for control of local tissue perfusion
in conditions of elevated blood and tissue temperature.
Source of temperature-dependent ATP release in
human blood
A key aim of the present study was to identify the source
of ATP release from blood components. With this aim,
we used an in vitro experimental set-up that excluded
the potential confounding influences of endothelial and
sympathetic nerve-derived ATP. The temperatures used
to heat whole blood, RBCs, plasma and serum (33–
42◦C; Fig. 1) cover the normal physiological temperature
range found in the human blood and muscle tissue
during exposure to environmental heat stress, external
heating and/or exercise (Saltin et al. 1972; Gonza´lez-
Alonso et al. 1999a,b). In the present in vivo study
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Table 3. Free haemoglobin levels in bathing solution after heating erythrocytes treated with niflumic acid, DIDS and
nitrobenzylthioinosine (NBTI)
Haemoglobin (g l−1)
Niflumic acid (μmol l−1) DIDS (μmol l−1) NBTI (nmol l−1)
Temperature (◦C) Control 100 200 400 100 200 400 50
33 0.15 ± 0.01 0.17 ± 0.02 0.16 ± 0.02 0.13 ± 0.02 0.13 ± 0.03 0.25 ± 0.04∗ 0.32 ± 0.05∗ 0.16 ± 0.03
39 0.09 ± 0.01 0.17 ± 0.03 0.16 ± 0.02 0.13 ± 0.01 0.16 ± 0.02 0.22 ± 0.02∗ 0.32 ± 0.04∗ 0.13 ± 0.02
Data are shown as means ± SEM, of n = 6. ∗Significantly different from control value P < 0.05.
specifically, quadriceps muscle temperature ranged from
34◦C in the resting control conditions to 41◦C during
combined heat stress and knee-extensor exercise (Fig. 7).
Thus, the design of this study also allowed the comparison
of the effect of graded increases in temperature on ATP
release from whole blood and its individual constituents
in vitro to the effect of whole-body heating in vivo.
An important observation of this study was that ATP
release from heated whole blood in vitro was significantly
elevated and, interestingly, reached comparable levels to
those found in the arterial plasma in vivo even though
the experimental conditions were vastly different. A
critical question is, which blood constituent accounts
for the increase in ATP? To answer this question, heat-
induced ATP release was measured from RBCs, plasma
and serum samples. We observed that ATP release from
RBCs increased progressively with temperature (r2 = 0.96;
P = 0.021) to levels higher than in whole blood or in
plasma during in vivo heating and exercise. In contrast,
heating plasma or serum did not elevate the free ATP
Figure 5. Release of ATP by venous erythrocyte samples heated
to 39◦C compared with control conditions (33◦C) in the
presence of 400 μmol l−1 niflumic acid (NFA) or 400 μmol l−1
glibenclamide (GLIB)
Open bars, ATP release at 33◦C; filled bars, ATP release at 39◦C.
Data are shown as means + SEM for nine subjects.
∗
Significantly lower than control 39◦C, P < 0.05. † Significantly
different from control conditions at 33◦C.
concentration with increasing temperature from 33 to
42◦C (Fig. 1C.). However, and in contrast to whole
blood, RBCs and plasma, a significant fall in serum
ATP was observed from the initial basal concentration
of 0.215μmol l−1 to >0.019μmol l−1 at all temperatures.
This indicates the presence of a high level of ATP
catabolic activity within the serum fraction in the
form of the soluble enzymes nucleoside triphosphate
diphosphohydrolase (NTPDase; known as ecto-ATPDase,
CD39), nucleotide pyrophosphatase (NPP) and hydrolase
plus ecto-5′-nucleotidase (Yegutkin et al. 2003), which
all work together to break down ATP. The difference in
catalytic activity of plasma ecto-5′-nucleotidase might
account for the drop in ATP levels in serum and the
maintenance of ATP in cell-free plasma (Coade&Pearson,
1989).
Critical to the interpretation of the present findings
is whether the observed increase in plasma or ‘bathing
solution’ ATP with elevations in temperature is due
to haemolysis and thus contamination from the higher
Figure 6. ELISA analysis of the binding capacity of CFTR on
protein isolated from RBC ghost membranes heated at 42◦C
relative to 33◦C (control)
Open bars, CFTR binding at 33◦C; filled bars, CFTR binding at
42◦C. Data are shown as means ± SEM for six subjects.
∗
Significantly different from 33◦C (control).
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intracellular ATP concentration in RBCs. To avoid this
possibility, blood samples were handled carefully while
centrifuging and pipetting, and the isolation procedure
did not include a wash step or resuspension step in a
buffer solution. In our study, plasma or ‘bathing solution’
free haemoglobin concentration remained unchanged
with increases in temperature from 33 to 42◦C in
RBC preparations (Table 1) and thus the temperature-
dependent increase in ATP was not correlated to free
haemoglobin (r2 = 0.48; P = 0.921). Furthermore, RBC
count, mean cell volume, mean cell haemoglobin and
mean corpuscular haemoglobin concentration did not
change, further suggesting that the rise in temperature
did not affect the volume and integrity of the blood
Figure 7. Relationship between quadriceps muscle
temperature and plasma ATP
Whole-body heat stress increases arterial plasma ATP levels with
both rest and exercise (r2 = 0.91; P < 0.0001). No significant
relationship was observed between venous plasma ATP levels
and muscle temperature (r2 = 0.61; P = 0.14). Open triangles
represent rest, whereas closed triangles represent exercise
measurements. Data are means ± SEM for 10 subjects.
cells. In addition, we reason that if the ATP release
was due solely to haemolysis, rather than a transport-
mediated process, it would not respond to any blocking
agent. In support of a transport-mediated process, we
found that ATP release was completely blocked with
400μmol l−1 niflumic acid or 400μmol l−1 glibenclamide
at 39◦C (Figs 4A, 5 and 8). Therefore, the short time for
which the erythrocytes were exposed to temperatures of
>36◦C in the present study did not cause any statistically
significant haemolysis. Moreover, any remaining plasma
and serum in the RBC fraction would contribute very
little to the observed fourfold increase in heat-induced
release of ATP fromRBCs (Fig. 1C andD). Taken together,
these findings demonstrate that the sole blood source of
temperature-dependent ATP release is the erythrocytes,
and the contribution fromother elementswithin theblood
is negligible.
Another key question is, how rapidly does temperature
increase ATP release from erythrocytes? As a first attempt
to answer this question, we heated the RBC solutions to
∼42◦C for different durations (1, 3, 5, 10 and 20min) and
compared resultswith control conditions at∼33◦C. In this
experimental setting, we observed a significantly higher
[ATP] in the ‘bathing solution’ after 1 min of incubation
at ∼42 compared with ∼33◦C and a significant increase
in ATP over time after 5 min in the heated conditions.
Although studies measuring ATP release in real time with
Figure 8. Release of ATP from arterial and venous erythrocyte
samples heated to 39◦C compared with control conditions
(33◦C) in the presence of 400 μmol l−1 NFA
Grey bars, arterial ATP release at 33◦C; open bars, venous ATP
release at 33◦C; grey hatched bars, arterial ATP release at 39◦C;
filled bars, venous ATP release at 39◦C. Data are shown as
means ± SEM for four subjects. Significantly different from
venous initial. † Significantly higher than venous initial, venous
control at 33◦C, venous NFA at 33◦C and venous NFA at 39◦C.
# Significantly lower than arterial control at 39◦C.
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sensors specific for ATP are required to assess the temporal
response to heating more precisely (Llaudet et al. 2005),
we believe that the observed differences in ATP after 1 min
of heating might have important regulatory implications
in vivo. For instance, in our recent isolated leg heating
study (Pearson et al. 2011) the leg blood flow increased
progressively from 0.5± 0.1 to 1.0± 0.1 l min−1 over the
1 h heating protocol, which was closely associated with
the gradual increase in muscle temperature. Moreover, we
have previously shown that a very low ATP infusion rate
of 200 nmol min−1 into the femoral artery, which does
not change plasma [ATP], can increase leg blood flow by
1 l min−1 (Gonza´lez-Alonso et al. 2002). It is therefore
reasonable to suggest that increases in intravascular ATP
have the potential to contribute to the vasodilatation in
the vasculature of the leg tissue seen during local heating
in vivo. Another important observation of this study was
the effect of cooling after heating, showing that ATP
release gradually returned to control values (Fig. 3). This
further supports the suggestion that heating per se does
not disturb the integrity of the RBCs or the functioning
of the ATP channels, and thus erythrocyte ATP release is a
true physiological response triggered by heating.
Mechanisms of temperature-dependent ATP release
from human erythrocytes
The present findings demonstrate that temperature is
an important physiological stimulus for the release of
ATP from human erythrocytes. A second aim of this
study was to gain insight into the temperature-sensitive
mechanisms of ATP release. There are several possible
pathways by which temperature might operate. First,
increases in temperature could affect the fluidity of the
erythrocyte membrane, which in turn could alter the lipid
and protein interactions and increase permeability for
ATP and other molecules. Although this is a reasonable
possibility when exposing RBCs to very high temperatures
(i.e. >48◦C), its relevance at the temperatures used in
this study (33–42◦C) seems to be minimal (Williamson
et al. 1975), because temperature-mediated erythrocyte
ATP release was completely blocked with either niflumic
acid or glibenclamide, despite the persistent high
temperature, and was fully restored with application of
cooling after heating. Second, ATP could be released
by diffusion down a gradient, because the intracellular
concentration of ATP in RBCs is ∼2mmol l−1, whereas
the plasma concentration in resting humans is normally
in the nanomolar range (Gonza´lez-Alonso et al. 2002;
Rosenmeier et al. 2004; Yegutkin et al. 2007; Dufour
et al. 2010; Mortensen et al. 2011). However, this is also
an unlikely possibility, because ATP is a large, charged
molecule and thus would not easily cross the cellular
membrane (Gordon, 1986).A third,more likely possibility
is that an active transporter or channel is responsible for
the controlled, temperature-dependentmovement of ATP
out of the erythrocyte.
Release of ATP from erythrocytes has been proposed
to involve membrane-bound ion channels, gap junction
proteins, such as pannexin 1, and/or the ATP-binding
cassette proteins, such as CFTR (Bergfeld & Forrester,
1992; Abraham et al. 1993; Locovei et al. 2006). There
are three observations in the present study that provide
strong support for the involvement of CFTR or CFTR-like
channels. First, we found that the temperature-mediated
erythrocyte ATP release was completely blocked with the
inhibitors of Ca2+-activated Cl− channels niflumic acid
and glibenclamide (a CFTR inhibitor), but not withDIDS.
This suggests the involvement of a Cl− channel that is
insensitive to DIDS, contrary to the study by Bergfeld &
Forrester (1992). The solubility of the different blockers
could be increased by temperature, and other unspecific
properties, such as lysis caused by DIDS, could be
resolved by washing away and then measuring the effects.
However, the temperature-sensitive channel proposed in
the present study could be similar to the erythrocyte
channel stimulated by deformation, also thought to be
CFTR, because both niflumic acid and glibenclamide
inhibited ATP release (Sprague et al. 1998). Furthermore,
previous work has demonstrated that niflumic acid can
also directly block the CFTR channel by inhibiting the
permeation of Cl− currents by plugging the channel
pore (Scott-Ward et al. 2004). Second, the presence of
NBTI did not block the heat-mediated ATP release from
the erythrocytes. This provides further evidence that the
temperature-sensitive channels in erythrocytes are not
affected by inhibitors of either nucleoside transport or
anion exchange (Bergfeld & Forrester, 1992). Finally,
CFTR protein abundance was increased, possibly due to
temperature-induced trafficking to the cell membrane or
demasking of epitope regions, because erythrocytes do not
have the necessary tools for protein synthesis (Denning
et al. 1992; Cheng et al. 2010). This temperature-mediated
CFTR translocation or activation could facilitate the
transport of ATP out of the RBCs. This is consistent with
the observation that ATP release induced by decreasing
pH also increased CFTR abundance in isolated skeletal
muscle cells (Tu et al. 2010). Taken as a whole, these
observations indicate that the increase in temperature-
stimulated erythrocyte ATP release might involve the
activation of erythrocyte CFTR or CFTR-like channels.
An alternative physiological mechanism that could
play a part in promoting the release of ATP when
temperature is increased is the shift in the oxyhaemoglobin
dissociation curve (Barcroft & King, 1909; Duc &
Engel, 1969). A rightward shift of the curve reflects a
reduction in the affinity of haemoglobin for oxygen that
could lead to an augmented oxygenation-coupled ATP
release from erythrocytes. Pioneering work demonstrated
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that erythrocytes release ATP in response to hypoxia
or independent reductions in PO2 and haemoglobin
oxygenation (Bergfeld & Forrester, 1992; Ellsworth et al.
1995; Sridharan et al. 2010). An important question is
therefore whether the presently observed increases in
erythrocyte ATP release with progressive elevations in
temperature are influenced by the oxygenation state of the
haemoglobin molecule and parallel changes in PO2 . The
evidence from our study suggests that the temperature
stimulus for erythrocyte ATP release differs from the well-
characterized stimulus coupled to the fall in PO2 and
oxyhaemoglobin (Ellsworth et al. 1995). For instance,
the parallel observation that femoral venous oxygenation
and PO2 increased during whole-body heating in vivo
accompanying an elevation of leg tissue blood flow, but
arterial oxygenation remainedunchangedandarterialATP
increased gradually with the rise in muscle temperature
(Pearson et al. 2011), supports a pathway of ATP release
that is independent of reductions in blood oxygenation.
This notion is further supported by the present in vitro
observation showing similar initial and control ATP levels
in arterial and venous plasma despite large differences
in haemoglobin oxygen saturation and PO2 (i.e. 98 versus
55% and 105± 1 versus 35± 4mmHg). Furthermore, any
differences with regard to affinity of arterial or venous
blood to the presence of niflumic acid were not apparent,
because they were both equally blocked to prevent heat-
induced ATP release. Taken together, the present findings
highlight a novel mechanism of temperature-dependent
ATP release from erythrocytes, which is independent of
the oxygen offloading from the haemoglobin molecules.
Physiological implications for the control of local
tissue perfusion
This study provides an insight into a potential mechanism
involved in the local control of blood flow during
conditions of increasing blood and tissue temperature,
such as exposure to heat stress, exercise, fever or thermal
therapy. Although increases in limb blood flow with heat
stress have generally been thought to be the sole response
to an augmented thermoregulatory demand of the skin
circulation (Rowell, 1974), evidence in pigs and humans
shows that skeletal muscle blood flow is also increased
with local and whole-body heating (Akyurekli et al. 1997;
Keller et al. 2010; Pearson et al. 2011), a response that is
closely related to the rise in local muscle temperature and
the arterial plasma concentration ofATPduring heat stress
at rest and during exercise (Pearson et al. 2011). Knowing
that muscle and capillary blood temperatures are similar
due to rapid temperature equilibration (He et al. 2002),
our parallel and present observations indicate that local
hyperthermia induces vasodilatation through increases in
intravascular ATP and/or other vascular signals sensitive
to temperature. ATP is an attractive mediator signal for
skeletal muscle blood flow control, because not only can
it act as a potent vasodilator, but also it has sympatholytic
properties in the leg and forearm (Rosenmeier et al. 2004;
Kirby et al. 2008), which are required to maintain or
increase perfusion in conditions of augmented muscle
sympathetic nerve activity, such as heat stress and
exercise (Niimi et al. 1997; Ray & Gracey, 1997; Pearson
et al. 2011).
The temperature-dependentmechanism of ATP release
from human erythrocytes documented in this study
opens the possibility of using external heating as a
non-pharmacological means of increasing limb tissue
perfusion, including that to skeletal muscle, in diseases
characterized by limb ischaemia. It is known that
circulatory problems associated with ageing and a number
of diseases, such as diabetes and peripheral vascular
disease, could benefit from increasing flow to limb tissues
that become deprived of oxygen and substrates (Feliciano
& Henning, 1999; Schrage et al. 2007; Black et al. 2008;
Kirby et al. 2010; Ruiter et al. 2010). Although decreased
cell-to-cell communication along vascular endothelium,
changes in receptor expression or damaged endothelium,
and impaired smooth muscle function could potentially
blunt the limb tissue hyperaemic response to heating
in some patient populations, studies using thermal
therapy or ‘forearm heat training’ have shown profound
muscle hyperaemia and beneficial endothelial adaptive
responses (Akyurekli et al. 1997; Green et al. 2010). It
would therefore be interesting to extend these studies by
investigating whether limb heating enhances ATP release
fromerythrocytes and increases skeletalmuscle bloodflow
in elderly people and different patient populations with
circulatory dysfunction.
In summary, our in vitro and in vivo findings
demonstrate that erythrocyte ATP release is sensitive
to physiological increases in temperature independent
of oxygenation, possibly by activation of a CFTR-like
channel. These data have potential clinical implications
for the treatment of patients with peripheral vascular
disease non-pharmacologically, by using local heating
to stimulate erythrocyte ATP release and thus increase
flow and oxygen and substrate supply to limb
tissues.
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